Samir Roy
14Patents
6h-index
27Co-inventors
66Inventor score
Filing activity: Apr 8, 1988 → Jan 24, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4906463A | Transdermal drug-delivery composition | Human Necessities | 191 | Expired |
| US5069909A | Transdermal administration of buprenorphine | Human Necessities | 189 | Expired |
| US5006342A | Resilient transdermal drug delivery device | Human Necessities | 150 | Expired |
| US5186939A | Laminated composite for transdermal administration of fentanyl | Human Necessities | 24 | Expired |
| US7056893B2 | Topical treatment for prevention of ocular infections | Human Necessities | 17 | Expired |
| US6265444A | Ophthalmic composition | Human Necessities | 16 | Expired |
| US6685958B2 | Quinolone carboxylic acid compositions and related methods of treatment | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6699492B2 | Quinolone carboxylic acid compositions and related methods of treatment | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7893042B2 | Phenazopyridine compounds | Chemistry; Metallurgy | 1 | Active |
| US10500215B2 | Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith | Human Necessities | 0 | Active |
| US12012370B1 | Sirtuin modulating compounds and applications thereof | Chemistry; Metallurgy | 0 | Active |
| US8288365B2 | Phenazopyridine compounds | Chemistry; Metallurgy | 0 | Active |
| US10137135B2 | Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith | Human Necessities | 0 | Active |
| US12215069B2 | Sirtuin modulating compounds and applications thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.